Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells
about
A functional and regulatory network associated with PIP expression in human breast cancerS100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathwaysOCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast CancerIn breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherinDysadherin: a new player in cancer progressionFXYD5: Na(+)/K(+)-ATPase Regulator in Health and DiseaseEpithelioid Sarcoma: Opportunities for Biology-Driven Targeted TherapyMonocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinomaDysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes.FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury.Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.FXYD5 (dysadherin) regulates the paracellular permeability in cultured kidney collecting duct cells.Breast cancer: coordinated regulation of CCL2 secretion by intracellular glycosaminoglycans and chemokine motifs.Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis.Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compoundsIL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesisModification of MCF-10A cells with pioglitazone and serum-rich growth medium increases soluble factors in the conditioned medium, likely reducing BT-474 cell growth.Role of chemokines in tumor growth.Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer.The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cellsEnhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers.FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells.The O-glycosylated ectodomain of FXYD5 impairs adhesion by disrupting cell-cell trans-dimerization of Na,K-ATPase β1 subunitsCWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatmentAutocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat dietChemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.HIF2α/EFEMP1 cascade mediates hypoxic effects on breast cancer stem cell hierarchy.Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.Importance of chemokine (CC-motif) ligand 2 in breast cancer.Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells.FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na+-K+-ATPase subunit in the 4T1 mouse breast cancer model.Dietary supplementation with curcumin enhances metastatic growth of Lewis lung carcinoma in mice.Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation.Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models.Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.ERalpha signaling through slug regulates E-cadherin and EMT.FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia.
P2860
Q21143857-951E55AC-C5C5-4E73-A5DC-491201A2B0ADQ24598566-DE02399C-2A32-415F-B486-25590EDEF83FQ24627533-F6174F0A-C627-4ECE-B1B9-5EE56581CDC1Q24653604-95180784-7489-446A-8C2A-05600D958D82Q24671729-75BCFB17-3F5A-4883-AEC5-37ACC46B449FQ26749337-373E5BE4-F944-4B9A-83B9-969B3B568C25Q26782730-83ACB463-8139-4003-996A-CDF88B477F9BQ33618672-1BBD1424-6411-42AE-8BDE-E7E380BEAB6EQ33648528-33F5D46F-87DF-4E6F-A4DC-43FC2E19FE3AQ33747385-B890B15E-8762-4B3B-BE1A-B774A575556BQ33803085-379D1D91-681D-406A-9C4F-DFDE1094EB3DQ34013449-C96E14F6-8D4C-421F-BAF9-1C92F923AE87Q34528303-5C618FEE-2E38-4F5F-AA80-857F5CABFBF6Q35310572-6FB87440-D22F-433B-B72F-D12FD85C94A6Q35541785-C944D51D-804C-490D-BA0E-7112DB9D201DQ35843010-2EA02792-B104-4803-9D45-55B57455A5FCQ35869752-885334E6-EBAE-4DA5-B952-F814E77F1D22Q36057300-20D08D75-F6F1-45E3-A52C-E13848A98BBCQ36120825-9452CB58-9E63-4D20-A9EE-B937B7EA37C4Q36186386-2CD78F69-907C-45B6-AB9E-B1401814920DQ36674940-AD85E435-964F-4F66-B9AB-C8209ED3FBDDQ36709856-2C130E43-D1A9-4F79-8DB2-76A63F55AD8FQ36987622-B34BF120-2342-486F-A5D4-8C7449CE0244Q37036438-93104B71-BAF0-4877-AA40-907C6EE05897Q37190326-EF2290B7-C33C-40C6-812F-3705A94FACE2Q37205843-3971511A-BABD-436F-9913-2CDCF96AB793Q37269450-67069329-45D5-447C-9D07-E766993DA109Q37431256-905C5379-0799-499B-9F51-FECD68BC2D98Q37536623-4AA9282F-7E9F-439A-A256-97CFC97BDA2CQ37696316-308C4C55-3714-45CB-BC37-4AEC0954A337Q37736204-BB18F51B-466D-4C48-9A9D-AA573CB13512Q38032234-A277369C-3EBD-46F3-AECB-704099F748ECQ38337275-AF5D3E03-396D-4227-B4BF-93DF99C33531Q38703189-B3C3FAA8-DE75-43E6-900D-36895467AADFQ39325941-86FFA871-1079-4A11-8BA6-DB566B5893D4Q39365972-539A56C3-8B60-4BB2-8390-7DFDF9D8C08AQ39367745-B0F4D8A7-38A4-4704-81CC-1ABEFDDAFB6BQ39587564-251601D4-E54D-4AF0-AACB-7326E82AD434Q39747936-844A32AF-2AF3-4AA0-A75D-C9E1B70ADC55Q40014753-6C816C9A-50CC-4BD4-8B06-272F694A404A
P2860
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Chemokine (C-C motif) ligand 2 ...... n in human breast cancer cells
@ast
Chemokine (C-C motif) ligand 2 ...... n in human breast cancer cells
@en
type
label
Chemokine (C-C motif) ligand 2 ...... n in human breast cancer cells
@ast
Chemokine (C-C motif) ligand 2 ...... n in human breast cancer cells
@en
prefLabel
Chemokine (C-C motif) ligand 2 ...... n in human breast cancer cells
@ast
Chemokine (C-C motif) ligand 2 ...... n in human breast cancer cells
@en
P2093
P2860
P1433
P1476
Chemokine (C-C motif) ligand 2 ...... n in human breast cancer cells
@en
P2093
Adam M Suchar
Aleksandra M Michalowska
Ethan A Kohn
Jeong-Seok Nam
Mi-Jin Kang
Setsuo Hirohashi
Takeshi Shimamura
V Craig Jordan
P2860
P304
P356
10.1158/0008-5472.CAN-06-0825
P407
P577
2006-07-01T00:00:00Z